The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Open accessAbstract
Chronic viral infections often result in T cell exhaustion. To determine the molecular signature of exhaustion, we compared the gene-expression profiles of dysfunctional lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells from chronic infection to functional LCMV-specific effector and memory CD8(+) T cells generated after acute infection. These data showed that exhausted CD8(+) T cells: (1) overexpressed several inhibitory receptors, including PD-1, (2) had major changes in T cell receptor and cytokine signaling pathways, (3) displayed altered expression of genes involved in chemotaxis, adhesion, and migration, (4) expressed a distinct set of transcription factors, and (5) had profound metabolic and bioenergetic deficiencies. T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes. Thus, functional exhaustion is probably due to both active suppression and passive defects in signaling and metabolism. These results provide a framework for designing rational immunotherapies during chronic infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T cells acquiring multiple inhibitory surface molecules in persistent disease settings such as chronic infection [37,38] and malignancies [30,**39,40], which effectively prevent T cell activation.”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [37]
In the citing paper
“Secretion of TNF-α in some populations of cells is reduced because of the contemporary arrest of p38-MAPK and PD-1 pathways.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“However, the telomerase activity in CD8+/CD45RA+ T cells is improved by blocking only the p38 pathway but not the PD-1 signaling, indicating that non-overlapping signaling pathways are involved (193, 194).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“In these cells that present characteristics of immune senescence (decreased proliferation, lower telomerase activity, and increased presence of DNA damage), the simultaneous blockade of both p38-MAPK and PD-1 signaling supports their proliferation, both in young and in older human beings.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationGreenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Self-citationWherry, E. J., Blattman, J. N., Murali‐Krishna, K., der Most, R. G. V., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,645
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,007
Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
ElTanbouly, M. A., & Noelle, R. J. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00454-2 · Cited by 282
Sheih, A., Voillet, V., Hanafi, L., DeBerg, H. A., Yajima, M., Hawkins, R. M., Gersuk, V. H., Riddell, S. R., Maloney, D. G., Wohlfahrt, M. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13880-1 · Cited by 268
Wirth, T. C., Xue, H., Rai, D., Sabel, J. T., Bair, T., Harty, J. T., & Badovinac, V. P. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.014 · Cited by 263
Tinoco, R., Alcalde, V., Yang, Y., Sauer, K., & Zúñiga, E. I. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.015 · Cited by 260
T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells
Beura, L. K., Wijeyesinghe, S., Thompson, E. A., Macchietto, M. G., Rosato, P. C., Pierson, M. J., Schenkel, J. M., Mitchell, J. S., Vezys, V., Fife, B. T., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.015 · Cited by 271
PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
Zinselmeyer, B. H., Heydari, S., Sacristán, C., Nayak, D., Cammer, M., Herz, J., Cheng, X., Davis, S. J., Dustin, M. L., & McGavern, D. B. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121416 · Cited by 271
Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway
Bowers, N. L., Helton, E. S., Huijbregts, R. P. H., Goepfert, P., Heath, S. L., & Hel, Z. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003993 · Cited by 256
Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
Reiser, J., & Banerjee, A. (2016) · Journal of Immunology Research · doi:10.1155/2016/8941260 · Cited by 262
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Attanasio, J., & Wherry, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.022 · Cited by 267
Self-citationTargeting T cell metabolism for therapy
O’Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 261
PD-1 marks dysfunctional regulatory T cells in malignant gliomas
Lowther, D. E., Goods, B. A., Lucca, L. E., Lerner, B. A., Raddassi, K., van Dijk, D., Hernandez, A., Duan, X., Günel, M., Coric, V., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85935 · Cited by 261
Abdel-Hakeem, M. S., Manne, S., Beltra, J., Stelekati, E., Chen, Z., Nzingha, K., Ali, M.-A., Johnson, J. L., Giles, J. R., Mathew, D., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00975-5 · Cited by 252
Self-citationEpigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans
Yates, K. B., Tonnerre, P., Martin, G. E., Gerdemann, U., Abosy, R. A., Comstock, D. E., Weiss, S. A., Wolski, D., Tully, D. C., Chung, R. T., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00979-1 · Cited by 257
Self-citationLiu, J., Zhang, E., Ma, Z., Wu, W., Kosinska, A. D., Zhang, X., Möller, I., Seiz, P. L., Glebe, D., Wang, B., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003856 · Cited by 257
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
LaFleur, M. W., Nguyen, T. H., Coxe, M. A., Miller, B. C., Yates, K. B., Gillis, J. E., Sen, D. R., Gaudiano, E. F., Abosy, R. A., Freeman, G. J., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0480-4 · Cited by 257
Self-citationFOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
Chan, J. D., Scheffler, C. M., Munoz, I., Sek, K., Lee, J. N., Huang, Y., Yap, K. M., Saw, N. Y. L., Li, J., Chen, A. X. Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07242-1 · Cited by 259
Collier, J. L., Weiss, S. A., Pauken, K. E., Sen, D. R., & Sharpe, A. H. (2021) · Nature Immunology · doi:10.1038/s41590-021-00949-7 · Cited by 237
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes
Long, S. A., Thorpe, J., DeBerg, H. A., Gersuk, V., Eddy, J. A., Harris, K. M., Ehlers, M., Herold, K. C., Nepom, G. T., & Linsley, P. S. (2016) · Science Immunology · doi:10.1126/sciimmunol.aai7793 · Cited by 250
Kansy, B., Concha‐Benavente, F., Srivastava, R. M., Jie, H.-B., Shayan, G., Lei, Y. L., Moskovitz, J. M., Moy, J. D., Li, J., Brandau, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3167 · Cited by 258
Inhibitory Receptors Beyond T Cell Exhaustion
Marraco, S. A. F., Neubert, N. J., Verdeil, G., & Speiser, D. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00310 · Cited by 250
Age-Associated B Cells: A T-bet–Dependent Effector with Roles in Protective and Pathogenic Immunity
Rubtsova, K., Rubtsov, A. V., Cancro, M. P., & Marrack, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501209 · Cited by 246
Duraiswamy, J., Ibegbu, C., Masopust, D., Miller, J. D., Araki, K., Doho, G., Tata, P., Sk, G., Zilliox, M. J., Nakaya, H. I., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001783 · Cited by 246
Self-citationCellular metabolism regulates the differentiation and function of T-cell subsets
Ma, S., Ming, Y., Wu, J., & Cui, G. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01148-8 · Cited by 276
Kim, C. G., Jang, M., Kim, Y., Leem, G., Kim, K. H., Lee, H., Kim, T.-S., Choi, S. J., Kim, H.-D., Han, J. W., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aay0555 · Cited by 245
Molecular and Cellular Functions of CTLA-4
Coillie, S. V., Wiernicki, B., & Xu, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_2 · Cited by 259
DuPage, M. J. P., Cheung, A. F., Mazumdar, C., Winslow, M. M., Bronson, R. T., Schmidt, L., Crowley, D. G., Chen, J., & Jacks, T. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.011 · Cited by 244
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
Boomer, J. S., Shuherk-Shaffer, J., Hotchkiss, R. S., & Green, J. M. (2012) · Critical Care · doi:10.1186/cc11404 · Cited by 244
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., et al. (2023) · Science · doi:10.1126/science.abo2296 · Cited by 243
Genetic and Epigenetic Regulation of PD-1 Expression
Bally, A. P. R., Austin, J. W., & Boss, J. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502643 · Cited by 254
CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells
Zhang, Y., Zhang, X., Cheng, C., Mu, W., Liu, X., Li, N., Wei, X., Liu, X., Xia, C., & Wang, H. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0543-6 · Cited by 239
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
Hoyt-Miggelbrink, A. M., Jackson, J. D., Lorrey, S., Srinivasan, E. S., Polania, J. W., Wilkinson, D. S., & Fecci, P. E. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0206 · Cited by 258
Suppression by TFR cells leads to durable and selective inhibition of B cell effector function
Sage, P. T., Ron‐Harel, N., Juneja, V. R., Sen, D. R., Maleri, S., Sungnak, W., Kuchroo, V. K., Haining, W. N., Chevrier, N., Haigis, M. C., et al. (2016) · Nature Immunology · doi:10.1038/ni.3578 · Cited by 247
Self-citationThe epigenetic control of stemness in CD8 + T cell fate commitment
Pace, L., Goudot, C., Zueva, E., Gueguen, P., Burgdorf, N., Waterfall, J. J., Quivy, J., Almouzni, G., & Amigorena, S. (2018) · Science · doi:10.1126/science.aah6499 · Cited by 232
Hepatitis E Virus-Related Cirrhosis in Kidneyand Kidney-Pancreas-Transplant Recipients
Kamar, N., Mansuy, J., Cointault, O., Sèlves, J., Abravanel, F., Danjoux, M., Otal, P., Esposito, L., Durand, D., Izopet, J., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02286.x · Cited by 235
The Contribution of Epigenetics to Cancer Immunotherapy
Villanueva, L., Álvarez‐Errico, D., & Esteller, M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.002 · Cited by 238
Wang, Y., Tong, C., Dai, H., Wu, Z., Han, X., Guo, Y., Chen, D., Wei, J., Ti, D., Liu, Z. Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20696-x · Cited by 241
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 232
Kaufmann, D., & Walker, B. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803771 · Cited by 229
Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition
Liu, X., Mo, W., Ye, J., Li, L., Zhang, Y., Hsueh, E. C., Hoft, D. F., & Peng, G. (2018) · Nature Communications · doi:10.1038/s41467-017-02689-5 · Cited by 224
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Schnell, A., Bod, L., Madi, A., & Kuchroo, V. K. (2020) · Cell Research · doi:10.1038/s41422-020-0277-x · Cited by 234
Mengel, M., Loupy, A., Haas, M., Roufosse, C. A., Naesens, M., Akalin, E., Groningen, M. C. C., Dagobert, J., Demetris, A. J., Huyen, J. D. V., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16059 · Cited by 228
High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells
Li, J., He, Y., Hao, J., Ni, L., & Dong, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02981 · Cited by 229
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking
Gunderson, A. J., Yamazaki, T., McCarty, K., Fox, N., Phillips, M., Alice, A. F., Blair, T. C., Whiteford, M. H., O’Brien, D. P., Ahmad, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15404-8 · Cited by 230
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
Ng, S. S., Rivera, F. D. L., Yan, J., Corvino, D., Das, I., Zhang, P., Kuns, R. D., Chauhan, S. B., Hou, J., Li, X.-Y., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0758-6 · Cited by 212
Vella, L. A., Giles, J. R., Baxter, A. E., Oldridge, D. A., Diorio, C. J., Kuri-Cervantes, L., Alanio, C., Pampena, M. B., Wu, J. E., Chen, Z., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7570 · Cited by 225
Self-citationDynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
Bénéchet, A. P., De Simone, G., Di Lucia, P., Cilenti, F., Barbiera, G., Le Bert, N., Fumagalli, V., Lusito, E., Moalli, F., Bianchessi, V., et al. (2019) · Nature · doi:10.1038/s41586-019-1620-6 · Cited by 222
The multifaceted immune regulation of bladder cancer
Schneider, A. K., Chevalier, M. F., & Derré, L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0226-y · Cited by 222
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
Labanieh, L., Majzner, R. G., Klysz, D. D., Sotillo, E., Fisher, C., Vilches-Moure, J. G., Pacheco, K. Z., Malipatlolla, M. B., Xu, P., Hui, J. H., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.041 · Cited by 232
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Liu, C., Martins, A. J., Lau, W. W., Rachmaninoff, N., Chen, J., Imberti, L., Mostaghimi, D., Fink, D. L., Burbelo, P. D., Dobbs, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.018 · Cited by 214
Understanding HIV Latency: The Road to an HIV Cure
Dahabieh, M. S., Battivelli, E., & Verdin, E. M. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-092112-152941 · Cited by 215
De novo design of protein logic gates
Chen, Z., Kibler, R. D., Hunt, A. C., Büsch, F., Pearl, J. R., Jia, M., VanAernum, Z. L., Wicky, B. I. M., Dods, G., Liao, H., et al. (2020) · Science · doi:10.1126/science.aay2790 · Cited by 211
Wieland, D., Kemming, J. S., Schuch, A., Emmerich, F., Knolle, P. A., Neumann‐Haefelin, C., Held, W., Zehn, D., Hofmann, M., & Thimme, R. (2017) · Nature Communications · doi:10.1038/ncomms15050 · Cited by 214
Revisiting Immune Exhaustion During HIV Infection
Khaitan, A., & Unutmaz, D. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0066-0 · Cited by 211
Subrata, L. S., Bizzintino, J. A., Mamessier, É., Bosco, A., McKenna, K. L., Wikström, M. E., Goldblatt, J., Sly, P. D., Hales, B. J., Thomas, W. R., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900695 · Cited by 210
Sun, J. C., López-Vergès, S., Kim, C. C., Derisi, J., & Lanier, L. (2011) · Journal of Immunology · doi:10.4049/jimmunol.1003035 · Cited by 215
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
Jayaraman, P., Jacques, M. K., Zhu, C. Y., Steblenko, K. M., Stowell, B. L., Madi, A., Anderson, A. C., Kuchroo, V. K., & Behar, S. M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005490 · Cited by 213
Williams, J. B., Horton, B. L., Zheng, Y., Duan, Y., Powell, J. D., & Gajewski, T. F. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160485 · Cited by 213
Li, J., Lee, Y., Li, Y., Jiang, Y. Y., Lu, H., Zang, W., Zhao, X., Liu, L., Chen, Y., Tan, H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.018 · Cited by 213
Si, J., Shi, X., Sun, S., Zou, B., Li, Y., An, D., Lin, X., Gao, Y., Long, F., Pang, B., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.001 · Cited by 209
TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance
Yang, Y., Kohler, M. E., Chien, C. D., Sauter, C. T., Jacoby, E., Yan, C., Hu, Y., Wanhainen, K., Qin, H., & Fry, T. J. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1209 · Cited by 208
Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function
Scharer, C. D., Barwick, B. G., Youngblood, B., Ahmed, R., & Boss, J. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301395 · Cited by 212
Self-citationIn vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer
Chen, Z., Arai, E., Khan, O., Zhang, Z., Ngiow, S. F., He, Y. M., Huang, H., Manne, S., Cao, Z., Baxter, A. E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.019 · Cited by 210
Self-citationYu, J. W., Bhattacharya, S., Yanamandra, N., Kilian, D., Shi, H., Yadavilli, S., Katlinskaya, Y. V., Kaczynski, H., Conner, M., Benson, W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206223 · Cited by 204
PD-1 regulates KLRG1+ group 2 innate lymphoid cells
Taylor, S. R., Huang, Y., Mallett, G., Stathopoulou, C., Felizardo, T. C., Sun, M., Martin, E. L., Zhu, N., Woodward, E. L., Elias, M. S., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161653 · Cited by 209
Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation
Hertoghs, K. M. L., Moerland, P. D., van Stijn, A., Remmerswaal, E. B. M., Yong, S. L., van de Berg, P. J. E. J., van Ham, S. M., Baas, F., ten Berge, I. J. M., & van Lier, R. A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42758 · Cited by 198
Webb, J. R., Milne, K., & Nelson, B. H. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0239 · Cited by 210
Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling
Yang, K., Blanco, D. B., Neale, G. A. M., Vogel, P., Ávila-Pacheco, J., Clish, C. B., Wu, C., Shrestha, S., Rankin, S. L., Long, L., et al. (2017) · Nature · doi:10.1038/nature23665 · Cited by 203
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
Catakovic, K., Klieser, E., Neureiter, D., & Geisberger, R. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-016-0160-z · Cited by 207
Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection
Aubert, R. D., Kamphorst, A. O., Sarkar, S., Vezys, V., Ha, S., Barber, D. L., Ye, L., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118450109 · Cited by 199
Self-citationIL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
Sun, Z., Fourcade, J. J., Pagliano, O., Chauvin, J.-M., Sander, C., Kirkwood, J. M., & Zarour, H. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3016 · Cited by 202
Activation or exhaustion of CD8+ T cells in patients with COVID-19
Rha, M., & Shin, E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00750-4 · Cited by 201
Park, Y., Kuen, D., & Chung, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0130-1 · Cited by 198
Taylor, A., Harker, J. A., Chanthong, K., Stevenson, P. G., Zúñiga, E. I., & Rudd, C. E. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.018 · Cited by 197
Atypical memory B cells in human chronic infectious diseases: An interim report
Portugal, S., Obeng-Adjei, N., Moir, S. L., Crompton, P. D., & Pierce, S. K. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.07.003 · Cited by 202
Kurachi, M., Kurachi, J., Suenaga, F., Tsukui, T., Abe, J., Ueha, S., Tomura, M., Sugihara, K., Takamura, S., Kakimi, K., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102101 · Cited by 189
Yamamoto, T., Price, D. A., Casazza, J. P., Ferrari, G., Nason, M., Chattopadhyay, P. K., Roederer, M., Emma Gostick, D., Katsikis, P. D., Douek, D. C., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317297 · Cited by 193
A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection
Crawford, A., Angelosanto, J., Nadwodny, K. L., Blackburn, S. D., & Wherry, E. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002098 · Cited by 197
Self-citationCalcium–NFAT transcriptional signalling in T cell activation and T cell exhaustion
Hogan, P. G. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.01.014 · Cited by 188
Wang, D., Prager, B. C., Gimple, R. C., Aguilar, B., Alizadeh, D., Tang, H., Lv, D., Starr, R., Brito, A., Wu, Q., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1243 · Cited by 185
Agarwal, S., Aznar, M. A., Rech, A. J., Good, C. R., Kuramitsu, S., Da, T., Gohil, M., Chen, L., Hong, S.-J. A., Ravikumar, P., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.001 · Cited by 199
Schurich, A., Pallett, L. J., Lubowiecki, M., Singh, H. D., Gill, U. S., Kennedy, P. T. F., Nastouli, E., Tanwar, S., Rosenberg, W. M., & Maini, M. K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003208 · Cited by 194
den Haan, J. M. M., Arens, R., & van Zelm, M. C. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.011 · Cited by 205
Baitsch, L., Legat, A., Barba, L., Marraco, S. A. F., Rivals, J., Baumgaertner, P., Christiansen-Jucht, C., Bouzourène, H., Rimoldi, D., Pircher, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030852 · Cited by 196
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
Mo, F., Yu, Z., Li, P., Oh, J., Spolski, R. J., Zhao, L., Glassman, C. R., Yamamoto, T. N., Chen, Y., Gołębiowski, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03861-0 · Cited by 178
Wang, Y., Zhong, H., Xie, X., Chen, C. Y., Huang, D., Shen, L., Zhang, H., Chen, Z. W., & Zeng, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501662112 · Cited by 185
Antonelli, L. R. D. V., Mahnke, Y. D., Hodge, J. N., Porter, B. O., Barber, D. L., DerSimonian, R., Greenwald, J. H., Roby, G. A., Mican, J. M., Sher, A., et al. (2010) · Blood · doi:10.1182/blood-2010-05-285080 · Cited by 182
Self-citationBastman, J. J., Serracino, H. S., Zhu, Y., Koenig, M. R., Mateescu, V., Sams, S. B., Davies, K. D., Raeburn, C. D., McIntyre, R. C., Haugen, B. R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4227 · Cited by 182
The function and dysfunction of memory CD 8+ T cells in tumor immunity
Reading, J. L., Gálvez‐Cancino, F., Swanton, C., Lladser, Á., Peggs, K. S., & Quezada, S. A. (2018) · Immunological Reviews · doi:10.1111/imr.12657 · Cited by 186
Chen, J. H., Nieman, L. T., Spurrell, M., Jorgji, V., Elmelech, L., Richieri, P. M., Xu, K. H., Madhu, R., Parikh, M., Zamora, I., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01792-2 · Cited by 204
A Distinct Subset of Self-Renewing Human Memory CD8+ T Cells Survives Cytotoxic Chemotherapy
Turtle, C. J., Swanson, H. M., Fujii, N., Estey, E. H., & Riddell, S. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.015 · Cited by 186
The Role of IL-10 in Regulating Immunity to Persistent Viral Infections
Wilson, E. B., & Brooks, D. G. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_96 · Cited by 177
Utzschneider, D. T., Alfei, F., Roelli, P., Barras, D., Chennupati, V., Darbre, S., Delorenzi, M., Pinschewer, D. D., & Zehn, D. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150598 · Cited by 177
Angelini, D. F., Serafini, B., Piras, E., Severa, M., Coccia, E. M., Rosicarelli, B., Ruggieri, S., Gasperini, C., Buttari, F., Centonze, D., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003220 · Cited by 177
Translation is actively regulated during the differentiation of CD8+ effector T cells
Araki, K., Morita, M., Bederman, A., Konieczny, B. T., Kissick, H. T., Sonenberg, N., & Ahmed, R. (2017) · Nature Immunology · doi:10.1038/ni.3795 · Cited by 166
Self-citationZhang, X., Zhang, C., Qiao, M., Cheng, C., Tang, N., Lu, S., Sun, W. C., Xu, B., Cao, Y., Wei, X., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.09.013 · Cited by 176
Polania, J. W., Hoyt-Miggelbrink, A. M., Tomaszewski, W. H., Wachsmuth, L. P., Lorrey, S., Wilkinson, D. S., Lerner, E., Woroniecka, K. I., Finlay, J. B., Ayasoufi, K., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.11.026 · Cited by 174
Chen, J. H., Perry, C. J., Tsui, Y., Staron, M. M., Parish, I. A., Dominguez, C. X., Rosenberg, D. W., & Kaech, S. M. (2015) · Nature Medicine · doi:10.1038/nm.3831 · Cited by 177
Self-citationType-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
Murira, A., & Lamarre, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00609 · Cited by 176
Lu, Y.-J., Barreira‐Silva, P., Boyce, S., Powers, J., Cavallo, K., & Behar, S. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109696 · Cited by 176
Dannenmann, S. R., Thielicke, J., Stöckli, M., Matter, C., von Boehmer, L., Cecconi, V., Hermanns, T., Hefermehl, L. J., Schraml, P., Moch, H., et al. (2013) · OncoImmunology · doi:10.4161/onci.23562 · Cited by 176
Metadata
- Authors
- Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R.
- Affiliations
- Emory University (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Wherry, E. John
- Ahmed, Rafi
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 27
- Issue
- 4
- Pages
- 670-684
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2040353461
- Cited by
- 2,103
- References
- 56
- Citations by year
- 2026: 110 · 2025: 148 · 2024: 140 · 2023: 144 · 2022: 139 · 2021: 180 · 2020: 161 · 2019: 138 · 2018: 119 · 2017: 102 · 2016: 112 · 2015: 116 · 2014: 88 · 2013: 83 · 2012: 80
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-11-26)
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2116 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI071309, AI 30048, R01AI071309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- CD8+ T cell exhaustion, chronic viral infection, lymphocytic choriomeningitis virus, PD-1, inhibitory receptors, T cell receptor signaling, cytokine signaling, T cell metabolism, bioenergetics, T cell migration, transcription factors, T cell anergy, gene expression profiling, immunotherapy
- MeSH terms
- Animals, Cell Differentiation, Chronic Disease, Female, Flow Cytometry, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Molecular Sequence Data, Phenotype, Virus Diseases, Gene Expression, Clonal Anergy, CD8-Positive T-Lymphocytes, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review